Details

---

Manufacturer
PT NOVELL PHARMACEUTICAL LABORATORIES.(INDONE SIA)

Registraction Number
MAL23036149AZ

Content:
Each modified release film-coated tablet contains:
Trimetazidine Dihydrochloride: 35 mg
Indications:
Stable Angina Pectoris: Used as add-on therapy for the symptomatic treatment of patients with stable angina pectoris who are inadequately controlled by or intolerant to first-line antianginal therapies.
Instructions:
Dosage: The recommended dose is one tablet taken twice daily, in the morning and evening, during meals.
Administration: Swallow the tablet whole with water. Do not crush or chew the tablet.